Health & Nutrition

bg
Wall Street banked on a flurry of deals under Trump in 2025. It wasn't that simple

Wall Street banked on a flurry of deals under Trump in...

Dealmakers expected a flood of M&A to take place in 2025 following the election...

bg
Inside the dealmaking that pushed Trump to reclassify pot, expand access

Inside the dealmaking that pushed Trump to reclassify pot,...

Trump’s pot executive order follows a yearlong industry push blending lobbying,...

bg
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

FDA approves first GLP-1 pill for obesity from Wegovy maker...

The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is...

bg
Novo Nordisk stock surges on hopes Wegovy pill approval will deliver 'redemption' for investors

Novo Nordisk stock surges on hopes Wegovy pill approval...

The FDA on Monday approved the first-ever GLP-1 pill for weight loss from the Danish...

bg
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Eli Lilly investors shouldn’t sweat rival Novo Nordisk...

Club holding Lilly stock slumped 1% Tuesday while Novo Nordisk shares jumped nearly...

bg
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Eli Lilly investors shouldn’t sweat rival Novo Nordisk...

Club holding Lilly stock slumped 1% Tuesday while Novo Nordisk shares jumped nearly...

bg
Is Aflatoxin a Concern?

Is Aflatoxin a Concern?

Is “toxic mold syndrome” a real thing? What do we do about toxic mold contamination...

bg
Can Vegan Fecal Transplants Lower TMAO Levels?

Can Vegan Fecal Transplants Lower TMAO Levels?

If the microbiome of those eating plant-based diets protects against the toxic effects...

bg
Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly

Healthy Returns: 2026 will be the year of obesity pills from...

2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and...

bg
Pfizer’s modest 2026 outlook shows its big investments will take time to pay off

Pfizer’s modest 2026 outlook shows its big investments...

Pfizer has pursued deals of all sizes to build new revenue streams, but the outlook...